Zobrazeno 1 - 10
of 5 979
pro vyhledávání: '"van de Velde, H."'
Publikováno v:
Studia Diplomatica, 1987 Jan 01. 40(6), 742-742.
Externí odkaz:
https://www.jstor.org/stable/44832587
Autor:
Regin M; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Lei Y; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Couvreu De Deckersberg E; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Janssens C; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Huyghebaert A; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Guns Y; Brussels Health Campus, Brussels IVF, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Verdyck P; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium.; Brussels Health Campus, Medical Genetics, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Verheyen G; Brussels Health Campus, Brussels IVF, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Van de Velde H; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium.; Brussels Health Campus, Brussels IVF, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Sermon K; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium., Spits C; Brussels Health Campus/Faculty of Medicine and Pharmacy, Research Group Genetics Reproduction and Development, Vrije Universiteit Brussel, Brussels, Belgium.
Publikováno v:
ELife [Elife] 2024 Dec 09; Vol. 12. Date of Electronic Publication: 2024 Dec 09.
Autor:
Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Blanco L; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Kim PS; Sanofi R&D, Cambridge, Massachusetts, USA., Bisht K; Sanofi R&D, Cambridge, Massachusetts, USA., Wang H; Sanofi R&D, Cambridge, Massachusetts, USA., Van de Velde H; Sanofi R&D, Cambridge, Massachusetts, USA., Lasa M; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Tamariz-Amador LE; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., San-Miguel J; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Martín-Sánchez E; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), CIBER-ONC Numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Dec; Vol. 205 (6), pp. 2262-2267. Date of Electronic Publication: 2024 Sep 22.
Autor:
Richardson PG; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. paul_richardson@dfci.harvard.edu., Perrot A; CHU Toulouse, IUCT-O, Université de Toulouse, UPS, Service d'Hématologie, Toulouse, France., Mikhael J; Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, AZ, USA., Martin T; Department of Medicine, University of California, San Francisco, CA, USA., Beksac M; Department of Hematology, Ankara University, Ankara, Turkey., Spicka I; General Faculty Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic., Capra M; Centro Integrado de Hematologia e Oncologia, Hospital Mãe de Deus, Porto Alegre, Brazil., D'Agostino M; Struttura Complessa (SC) Ematologia, Azienda Ospedaliero-Universitaria (AOU) Città della Salute e della Scienza di Torino, Turin, Italy., Sonneveld P; Erasmus University Medical Center Cancer Institute, Rotterdam, The Netherlands., Bisht K; Sanofi, Cambridge, MA, USA., Fukao T; Sanofi, Cambridge, MA, USA., Zhang R; Sanofi, Cambridge, MA, USA., Tada K; Sanofi, Tokyo, Japan., Tekle C; Sanofi, Cambridge, MA, USA., Macé S; Sanofi, Chilly-Mazarin, France., Klippel Z; Sanofi, Cambridge, MA, USA., van de Velde H; Sanofi, Cambridge, MA, USA., Moreau P; Hematology Department, CHU Nantes, Nantes, France.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2024 Nov 28; Vol. 14 (1), pp. 209. Date of Electronic Publication: 2024 Nov 28.
Autor:
Bisht K; Research and Development, Sanofi, Cambridge, MA, 02141, USA. kamlesh.bisht@sanofi.com., Merino A; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis-Saint Paul, MN, USA., Igarashi R; Research and Development, Sanofi, Cambridge, MA, 02141, USA., Gauthier L; Innate Pharma Research Laboratories, Innate Pharma, Marseille, France., Chiron M; Research and Development, Sanofi, Vitry-sur-Seine, France., Desjonqueres A; Research and Development, Sanofi, Cambridge, MA, 02141, USA., Smith E; Division of Hematologic Malignancies and Transplantation, Dana Farber Cancer Institute, Boston, MA, USA., Briercheck E; Division of Hematologic Malignancies and Transplantation, Dana Farber Cancer Institute, Boston, MA, USA., Romee R; Division of Hematologic Malignancies and Transplantation, Dana Farber Cancer Institute, Boston, MA, USA., Alici E; Department of Medicine, Karolinska Institutet (KI), Huddinge, Sweden., Vivier E; Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.; Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, CNRS, INSERM, Marseille, France.; Marseille-Immunopôle, APHM, Hôpital de la Timone, Marseille, France., O'Dwyer M; Department of Haematology, University of Galway, Galway, Ireland., van de Velde H; Research and Development, Sanofi, Cambridge, MA, 02141, USA.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Nov 13; Vol. 13 (1), pp. 114. Date of Electronic Publication: 2024 Nov 13.
Autor:
Kapoor P; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Nathwani N; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, California, USA., Jelinek T; Department of Hematooncology, University Hospital Ostrava and University of Ostrava, Ostrava, Czech Republic., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Perrot A; Department of Hematology, Institut Universitaire du Cancer de Toulouse, Toulouse, France., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece., Huang SY; Department of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Spicka I; First Department of Medicine, Department of Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic., Chhabra S; Division of Hematology and Oncology, Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA., Lichtman E; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), University of Salamanca, Salamanca, Spain., Kanagavel D; Research and Development, Sanofi, Research and Development, Vitry-sur-Seine, France., Zhao L; Research and Development, Sanofi, Research and Development, Shanghai, China., Guillemin-Paveau H; Research and Development, Sanofi, Research and Development, Vitry-sur-Seine, France., Macé S; Research and Development, Sanofi, Research and Development, Vitry-sur-Seine, France., van de Velde H; Research and Development, Sanofi, Research and Development, Cambridge, Massachusetts, USA., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Jerome Lipper Multiple Myeloma Center, Boston, Massachusetts, USA.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Nov; Vol. 113 (5), pp. 593-605. Date of Electronic Publication: 2024 Jul 12.
Autor:
Wouters K; Brussels IVF, UZ Brussel, Jette, Belgium., Mateizel I; Brussels IVF, UZ Brussel, Jette, Belgium., Segers I; Brussels IVF, UZ Brussel, Jette, Belgium., Van de Velde H; Brussels IVF, UZ Brussel, Jette, Belgium., Van Landuyt L; Brussels IVF, UZ Brussel, Jette, Belgium., De Vos A; Brussels IVF, UZ Brussel, Jette, Belgium., Schoemans C; Brussels IVF, UZ Brussel, Jette, Belgium., Jankovic D; Brussels IVF, UZ Brussel, Jette, Belgium., Blockeel C; Brussels IVF, UZ Brussel, Jette, Belgium., Drakopoulos P; Brussels IVF, UZ Brussel, Jette, Belgium., Tournaye H; Brussels IVF, UZ Brussel, Jette, Belgium., De Munck N; Brussels IVF, UZ Brussel, Jette, Belgium.
Publikováno v:
Human reproduction (Oxford, England) [Hum Reprod] 2024 Oct 01; Vol. 39 (10), pp. 2233-2239.
Autor:
Capalbo A; Juno Genetics, Department of Reproductive Genetics, Rome, Italy.; Center for Advanced Studies and Technology (CAST), Department of Medical Genetics, 'G. d'Annunzio' University of Chieti-Pescara, Chieti, Italy., de Wert G; Department of Health, Ethics & Society, CAPHRI-School for Public Health and Primary Care and GROW School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands., Mertes H; Department of Philosophy and Moral Sciences, Ghent University, Ghent, Belgium.; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium., Klausner L; Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel., Coonen E; Departments of Clinical Genetics and Reproductive Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.; School for Oncology and Developmental Biology, GROW, Maastricht University, Maastricht, The Netherlands., Spinella F; Eurofins GENOMA Group Srl, Molecular Genetics Laboratories, Department of Scientific Communication, Rome, Italy., Van de Velde H; Research Group Genetics Reproduction and Development (GRAD), Vrije Universiteit Brussel, Brussel, Belgium.; Brussels IVF, UZ Brussel, Brussel, Belgium., Viville S; Laboratoire de Génétique Médicale LGM, Institut de Génétique Médicale d'Alsace IGMA, INSERM UMR 1112, Université de Strasbourg, France.; Laboratoire de Diagnostic Génétique, Unité de Génétique de l'infertilité (UF3472), Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Sermon K; Research Group Genetics Reproduction and Development (GRAD), Vrije Universiteit Brussel, Brussel, Belgium., Vermeulen N; ESHRE Central Office, Strombeek-Bever, Belgium., Lencz T; Institute of Behavioral Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA.; Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA., Carmi S; Braun School of Public Health and Community Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Publikováno v:
Human reproduction update [Hum Reprod Update] 2024 Oct 01; Vol. 30 (5), pp. 529-557.
Autor:
Martín-Sánchez E; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Blanco L; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Kim PS; Sanofi R&D, North America, Cambridge, MA., Bisht K; Sanofi R&D, North America, Cambridge, MA., Wang H; Sanofi R&D, North America, Cambridge, MA., Van de Velde H; Sanofi R&D, North America, Cambridge, MA., Jelinek T; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.; Department of Hematooncology, University Hospital of Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Simoes C; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Prosper F; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., San Miguel JF; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Alfonso A; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Bergua J; Hospital San Pedro de Alcántara, Cáceres, Spain., Rodríguez-Veiga R; Hospital Universitario La Fe, Valencia, Spain., Vives S; Institut Català d'Oncologia Badalona-Hospital Germans Trias I Pujol, Josep Carreras Research Institute, Badalona, Spain., Martínez-Cuadrón D; Hospital Universitario La Fe, Valencia, Spain., Montesinos P; Hospital Universitario La Fe, Valencia, Spain., Paiva B; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain., Zabaleta A; Cancer Center Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, Instituto de Investigación Sanitaria de Navarra, CIBER-ONC numbers CB16/12/00369 and CB16/12/00489, Pamplona, Spain.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 3875-3879.
Autor:
Verloes, A., Spits, C., Vercammen, M., Geens, M., LeMaoult, J., Sermon, K., Coucke, W., Van de Velde, H.
Publikováno v:
In Stem Cell Research March 2017 19:118-127